Prior anticoagulant therapy, subtherapeutic international normalized ratio and thrombolytic therapy in acute ischemic stroke

International Journal of Stroke

Volumn 6, Issue 6, 2011, Pages 568-569

  Miedema, Irene ^a   Gosselt, Alex ^a   de Keyser, Jacques ^b   Koopman, Karen ^a   Kremer, Berry ^a   Luijckx, Gert Jan ^a   Uyttenboogaart, Maarten ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DISEASE ASSOCIATION; DRUG USE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

ANTICOAGULANTS; BRAIN ISCHEMIA; HUMANS; INTERNATIONAL NORMALIZED RATIO; PROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; VITAMIN K;

EID: 82255186196     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00669.x     Document Type: Letter

References (4)

1. Adams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38:1655-711.
2. Prabhakaran S, Rivolta J, Vieira JR et al. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2010; 67:559-63.
3. Janjua N, Alkawi A, Georgiadis A et al. Feasibility of IA thrombolysis for acute ischemic stroke among anticoagulated patients. Neurocrit Care 2007; 7:152-5.
4. Kim YD, Lee JH, Jung YH et al. Safety and outcome after thrombolytic treatment in ischemic stroke patients with high-risk cardioembolic sources and prior subtherapeutic warfarin use. J Neurol Sci 2010; 298:101-5.